EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regulatory effects of berberine on intestinal microecology in mice with ulcerative colitis

Xinyi Xu, Bin Zhao, Pingyu Liu, Xiaohui Tang, Zonglang Lai, Na Song, Jun Cheng

Frontiers in Microbiology · 12.11.2025 · 16

DOI: 10.3389/fmicb.2025.1649947 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.11.2025. Verfasst von Xinyi Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Shanghai Medical College, Fudan University, Shanghai, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Project of Performance Incentive Guidance for Scientific Research Institutions in Chongqing, Chongqing Medical Scientific Research Project, Joint Project of Jiangbei District Health Commission and Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Currently, therapeutic approaches for ulcerative colitis (UC), such as aminosalicylates, glucocorticoids, and biologics, exhibit certain efficacy but are hindered by limitations including side effects, high costs, or suboptimal responses. As a traditional Chinese medicine component, berberine (BBR) possesses anti-inflammatory properties and the ability to modulate the gut microbiota, with low toxicity, and may provide new directions for UC treatment in the future.

Methods

A mouse UC model was established via dextran sulfate sodium (DSS) induction, and dose-and time-dependent screening was performed to determine the optimal BBR dosage and intervention duration for subsequent experiments. The disease activity index (DAI) and colon length were measured. Colonic tissue changes were observed via HE staining. Serum cytokine levels (IL-1 β , TNF- α , IL-10, TGF- β ) were detected using ELISA. The expression levels of ZO-1 and Occludin in mouse colonic tissues were detected by WB. Further analyses included 16S rRNA sequencing to assess gut microbiota diversity and composition, untargeted metabolomics to identify differential metabolites in intestinal tissues, and Mendelian randomization (MR) analysis to explore causal associations among intestinal genes, circulating metabolites, and key bacterial genera. Finally, functional validation was performed by inhibiting the PDGFA receptor.

Results

Berberine significantly alleviated the DAI score, colonic pathological damage, and cytokine imbalance in UC mice, as well as restored mucosal barrier integrity, with the most pronounced effects observed in the UC + low-BBR 14 days group. Gut microbiota analysis revealed distinct microbial structures across groups, with the UC + low-BBR 14 days group showing significantly higher relative abundances of Bacteroides , Alistipes , and unclassified_Clostridia_vadinBB60_group compared to the UC group ( p < 0.05). Metabolomics analysis indicated that berberine altered the composition of intestinal tissue metabolites and metabolic pathways. MR analysis demonstrated inverse causal associations between PDGFA and lithocholate sulfate, as well as between lithocholate sulfate and Alistipes . Additionally, inhibition of the PDGFA receptor reversed the therapeutic effects of BBR, exacerbating inflammatory responses and intestinal mucosal barrier damage. Finally, the correlation analysis between gut microbiota and metabolites also confirmed that the abundance of the genus Alistipes exhibited a highly significant negative correlation with lithocholate sulfate levels ( p < 0.001).

Conclusion

Berberine ameliorates symptoms of UC in mice by regulating gut microbiota and metabolite composition. MR analysis first establishes a unidirectional causal chain of PDGFA/lithocholate sulfate/ Alistipes , and animal experiments confirm that blocking the PDGFA receptor reverses its therapeutic effects and aggravates inflammation and intestinal mucosal injury.

Schlagwörter

Stichwörter der Autor:innen

Mendelian randomizationberberinegut microbiotametabolitesulcerative colitis

Autor:innen und Institutionen

  • Graduate School of Shanghai Medical College, Fudan University, Shanghai, China.
  • Chongqing Shapingba Hospital of Traditional Chinese Medicine, Chongqing, China.
  • Institute of Literature in Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Oncology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.

Förderung

  • Special Project of Performance Incentive Guidance for Scientific Research Institutions in Chongqing
  • Chongqing Medical Scientific Research Project
  • Joint Project of Jiangbei District Health Commission and Science and Technology Bureau

Zitieren

APA

Xu, X., Zhao, B., Liu, P., Tang, X., Lai, Z., Song, N., & Cheng, J. (2025). Regulatory effects of berberine on intestinal microecology in mice with ulcerative colitis. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1649947

Vancouver

Xu X, Zhao B, Liu P, Tang X, Lai Z, Song N, et al. Regulatory effects of berberine on intestinal microecology in mice with ulcerative colitis. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1649947

BibTeX
@article{Xu2025,
  author = {Xu, Xinyi and Zhao, Bin and Liu, Pingyu and Tang, Xiaohui and Lai, Zonglang and Song, Na and Cheng, Jun},
  title = {Regulatory effects of berberine on intestinal microecology in mice with ulcerative colitis},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1649947}
}
Kostenlos starten →